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Miniaturization of coordination polymers to the nanoscale represents a unique 
opportunity to assemble a novel class of highly customizable functional materials that 
marry the rich diversity, chemistry and properties of coordination complexes to the 
advantages of nanomaterials. The new structures, which exhibit well-defined and 
dispersed morphologies, can allow for a proper correlation with their functionality, and 
therefore, enable the rational design of new generations of these nanostructures 
targeting specific desired properties.  
In this Chapter we will give a brief introduction to the rational fabrication of such 
functional nanostructures following different coordination polymerization mechanisms. 
The novel “smart” nanoscale coordination polymer particles (NCPs) exhibit interesting 
properties of relevance for different fields and applications, worth to mention 
Nanomedicine and Sensors.  
Herein we make a summary of the main results obtained in both areas that evidence the 
significance of this novel family of materials. For this, the review has been divided into 
two main sections. In the first part we revise general methodologies for cargo loading 
and delivery, including the design of stimuli-responsive systems. In the second section 
we will review the latest advances in the use of NCPs as chemical sensing platforms. 
These results open new avenues for all the possible applications that can be derived 
from the implications of CPPs on surfaces. Finally, a brief introduction to the new 











The self-assembly of coordination polymers (CPs) at the nanoscale represents a novel 
opportunity to develop a unique class of highly tailorable functional materials that 
combines the rich diversity of CPs with the advantages of nanomaterials. The synthetic 
flexibility of directional metal-ligand bonds is used to systematically control and tune 
the chemical topology, nanodimensions and morphologies of the corresponding 
materials. The limitless choice of metallic elements ensures a broad range of interesting 
magnetic, electronic, optical, and catalytic properties. And finally, miniaturization to the 
nanometer scale improves their colloidal stability, increases the surface area (and 
therefore the catalytic, sensing or storage capabilities) and is used to systematically fine-
tune the physical properties of the materials. All of these advantages are highly required 
for most envisioned applications.1  
So far, two main families of CPs at the nanoscale have been described:  
• Amorphous coordination polymer nanoparticles, referred from now on as nanoscale 
coordination polymers (NCPs),2 also called infinite coordination polymers (ICPs)3 or 
coordination polymer particles (CPPs).4  
• Nanoscale crystalline and porous coordination polymer structures, from now on 
NMOFs.  
NMOFs exhibit exceptionally high surface areas and loading capacities while allow for 
control over the release of cargo via modification of tunable pores. The crystalline 
nature of MOFs also facilitates analyses of host–guest interactions and therefore a 
systematic design and optimization of drug encapsulation and release studies. As a 
result of these interests, several comprehensive reviews summarizing progress in MOFs 
for applications are available elsewhere,5 being the nanomedicine of the emerging areas 
of interest over the last years.6 On the other hand, NCPs have emerged as an alternative 
to NMOFs. This new family of nanoparticles are amorphous with spherical morphologies 
ranging from a few to hundreds of nanometers in size. The most common synthetic 
approach to obtain NCPs is mixing metal ions and the corresponding organic ligands in 
the presence of a poor solvent that induces a fast precipitation, i.e. using out-of-
equilibrium conditions.7 To minimize the interfacial free energy between the surface of 
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the NCPs and the solvent during the reaction, the nanoparticles acquire the spherical 
shape. Other approaches to obtain NCPs have been described:8 worth to mention are 
reverse micro-emulsions,9 lab-on-a-chip implementation10 and Dip-Pen 
Nanolithography (DPN).11 
Since first reported in 2005 by Mirkin12 and Wang,13 the number of publications related 
with NCPs is growing exponentially along with the variety of applications exemplified, 
including heterogeneous catalysis,14 spin-crossover,10,15 separation of oils from water,16 
bio-sensing,17 pH sensors,18 gas absorption systems,19 hybrid nanoparticle-based 
devices,20 fluorescent sensors,21 precursors for inorganic particles22 and thermochromic 
nanostructures.23 Especial mention deserves the application of NCPs in medicine. With 
this aim, drugs can be trapped as constitutive building blocks of the polymeric unit 
(chemical entrapment) or through the physical encapsulation inside the nanoparticle.24 
Physical encapsulation of active substances such as organic dyes, magnetic 
nanoparticles, or luminescent quantum dots was already reported back in 2009.25 One 
year later, the same authors showed that these capsules not only can encapsulate but 
also can release active principles as polymeric nanoparticles do.25 On the other side, 
chemical entrapment allows for a better fine-tuning of the release kinetics (up to many 
hours) as well as better formulation with increased encapsulation yields. The use of 
active metal drugs, such as Pt(IV),26 as polymeric nodes of coordination polymers 
represents the most successful example of chemical entrapment. Less explored has 
been the chemical entrapment through tethering of active drugs as chelating ligands, in 
spite of the fact that its efficiency has already been reported.27 Moreover, the chemical 
flexibility of organic synthesis may allow for the design of drugs (ligands) cleaved under 
physiological conditions.28 Together, encapsulation capabilities, nanodimensions and 
excellent colloidal and chemical stabilities have allowed for their use in medical 
applications. 
Beyond their use in Nanomedicine, the scope of application of NCPs nanoparticles as 
platforms for chemical sensing has also grown exponentially in the last years.28 
Lanthanide-based NCPs nanoparticles constitute the main class of these nanostructures 
used as sensors for different chemical species, based on its performance in enhancing 
or quenching the fluorescence of a sample in the presence of a certain analyte. 
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Herein we make a summary of the main results obtained in both areas that evidence the 
significance of this novel family of materials. For this, the review has been divided into 
two main sections. In the first part we revise general methodologies for cargo loading 
and delivery, including the design of stimuli-responsive systems. In the second section 
we will review the latest advances in the use of NCPs as chemical sensing platforms. 
Rather than a detailed list of examples and specific cases reported so far, it is our aim to 
go deeper into the mechanistic details of their behavior. 
 
2. Nanoscale Coordination Polymers for Drug Delivery 
 
2.1. Encapsulation and release approaches 
As mentioned above, cargo loading is accomplished either via direct incorporation of 
active drugs as NCPs building blocks (metal ions or organic ligands) or via guest 
encapsulation during NCPs synthesis or in a post-synthetic step. Following this approach 
we can achieve high drug loadings, although the morphology and physicochemical 
properties are difficult to control. Using the second approach, we have more control 
over the morphology but overall the active drugs are incorporated in lower amounts and 
their loading strongly depends on the physicochemical properties of each drug (leakage 
can occur). Amorín-Ferré et al. illustrated the differences between both encapsulation 
approaches and their drug release kinetics (Figure 1).24 NCPs composed by Co(II), 1,4-
bis(imidazol-1-ylmethyl)benzene (bix) and 3,5-di-tert-butylcatechol, were formed in the 
presence of fluorescent compounds, either containing a free chelating catechol 
(coordination to the main backbone takes place) or a protected one (physical 
entrapment). Cargo loading via direct attachment to the NCPs framework, was slowly 
released only upon particle degradation, whereas the encapsulated one was easily 
released through a diffusion mechanism. On the other hand, Novio et al. reported the 
formation of catechol-iron based NCPs containing carboxylic groups as platforms for 
further functionalization via condensation reactions.29 As a proof-of-concept, the 
particles were covalently labelled with bioactive functional moieties as a fluorescent dye 
or polyethylene glycol (PEG). The particles showed efficient cellular uptake and no 
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significant cytotoxicity. Their use as drug delivery platforms was then modeled by 
encapsulating the anticancer drug camptothecin, showing an improvement in IC50 values 
as compared with the free drug.29  
 
Insert Figure 1 here 
 
Figure 1. (a) Chemical structures of fluorescent guest compounds 1 and 2 used in the formation of 
structural-analogous of M1 and M2 particles, used to investigate degradation and diffusion-controlled 
release in NCPs. (b and c) SEM (left) and TEM (right) images of M1 (b) and M2 (c) particles. Scale bars for 
SEM are 1 µm and 200 nm for TEM. (d) Release profiles of fluorescent guest molecules from M1 (□) and 
M2 (○) at 37 °C, averaged over four independent experiments. Reproduced from reference 24 with 
permission of the copyright holder. 
 
Liang et al. synthesized nanowire coils of organometallic coordination polymers by using 
the emulsion polymerization technique.30 The nanowires were formed by the self-
assembly of a triblock copolymer terminated with a complex of β-cyclodextrin and 4,4’-
bipyridine and their subsequent polymerization using Ni(II). The resulting material was 
able to incorporate hydrophobic organic cargoes, as showed by the encapsulation of 
model hydrophobic dye Nile red. Li et al. reported nanostructures made by the self-
assembly of curcumin, amino acids and Zn(II).31 The nano-structuration of the curcumin 
molecule helped to overcome its quick degradation in physiological media. Additionally, 
tumor accumulation and inhibition was enhanced when curcumin was delivered as 
NCPs. Li et al. illustrated the feasibility of NCPs for macromolecule delivery with the 
report of iron-induced DNA self-assemblies.32 The resulting nanostructures could be 
fine-tuned by modifying the Fe/nucleotide ratio or their concentration during the 
reaction mixture. Although DNA is unable to penetrate cell membranes, its 
nanoassembly allowed an efficient cellular uptake, reported mainly in endosomes or 
lysosomes. In vitro and in vivo studies showed the potentiality for DNA delivery using 
CpG, an immune stimulatory DNA. 
Fan et al. developed an interesting strategy for monitoring drug release in real time 
based on the self-assembly of a tryptophan-phenylalanine dipeptide with Zn(II) ions to 
form dipeptide nanoparticles (DNPs).33 DNPs were found to display fluorescence in the 
visible range and possessed advantages over organic fluorophores, quantum dots or 
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green fluorescent proteins like photo- and thermal stability, biocompatibility and 
narrower emission bandwidth. Conjugation of the chemotherapeutic drug doxorubicin 
through π-π stacking, afforded DNPs able to experience release (50% in 24 h, pH 6.0), 
which could be then monitored in vitro due to their fluorescent properties. Bertleff-
Zieschang et al. described an approach for the coordination-driven assembly of different 
flavonoids and Fe(III) ions, which could be either used for the preparation of films or 
microcapsules after template removal.34 The resulting structured flavonoids displayed 
higher antioxidant activity than in the free form and was preserved over multiple 
scavenging cycles.  
 
2.2. Stimuli-responsive delivery platforms  
The high degree of tune ability in the design of NCPs allows the fabrication of materials 
with responsive properties. Several examples have been reported in which an external 
stimulus is able to trigger a more controlled drug delivery. Probably the most relevant 
stimulus is pH, because of both the pH-dependence nature of coordination bonds and 
the relevance of pH variations within intra- and extracellular environments. Other 
potential stimuli for cargo release might include redox- or light-responsive materials. 
pH-responsive 
Gao et al. reported nanoparticles composed by the self-assembly of iron ions and 1,1’-
(1,4-butanediyl)bis(imidazole) and the subsequent encapsulation of doxorubicin 
hydrochloride (40% drug loading content) followed by silica coating.35 Interestingly, 
these particles exhibited sustainable drug release for several days, which was 
significantly faster at pH 5.0 than under physiological conditions. Another example of 
pH-dependent doxorubicin delivery using NCPs was reported by Bai et al.36 In this work, 
a triblock copolymer composed by poly(ethylene glycol)-b-poly(2-hydroxyethyl 
methacrylate-Boc-histidine)-b-poly(styrene) (PEG-PBHE-PS) was prepared and self-
assembled into micelles. Further polymerization of histidine moieties, doxorubicin and 
Cu(II) allowed the formation of micelles with a drug loading as high as 26.1%. Due to the 
pH-dependence of the stability of the coordination bonds between copper, histidine and 
doxorubicin, drug leakage was strongly suppressed at physiological pH but drug release 
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was drastically increased at pH 5.0. Further studies using doxorubicin included NCPs 
composed by an iron(III)-gallic acid network that could potentially encapsulate 
doxorubicin up to 93.5% drug loading content by its coordination with the Fe(III) 
centers.37 In this work, Han et al. showed that these acid-sensitive NCPs allowed a real-
time drug release monitoring into lysosomes, as doxorubicin inherent fluorescence was 
quenched when the polymer was nanostructured but recovered as doxorubicin was 
released due to the acidity in lysosomes. Moreover, in vivo evaluation showed 
significant tumor growth inhibition with minimal heart toxicity. 
Xu et al. proposed a strategy for releasing Fe-salphen complexes using core-shell 
nanoparticles composed by a Fe3O4 core and a salphen-In(III) coordination polymer 
shell.38 Using this approach, the polymeric shell was observed to rapidly hydrolyze at pH 
5.0, while the Fe3O4 core slowly collapsed to release iron ions chelated by salphen and 
form the active therapeutic species. In vitro studies determined significant selectivity for 
cancer cells and IC50 values comparable to those of pharmaceutically-active Mn(II)-salen 
complexes. 
Wang et al. exploited the lability of metal-ligand bonds to cap titanium nanotubes (TNTs) 
containing antibacterial agents using coordination polymers.39 In this work, TNTs were 
loaded with model drugs ibuprofen, vancomycin or Ag nanoparticles and then capped 
by the bix ligand and Zn(II) or Ag(I) ions. At physiological pH, drug release was found to 
be blocked, however it increased as pH decreased, due to the degradation of the 
coordination polymer. In addition, metal ions could offer favorable biological functions: 
Zn(II) could promote the proliferation of osteoblastic cells while Ag+ exhibited 
antibacterial properties. 
Ejima et al. took advantage of the pH dependency in Fe(III)-catechol coordination by 
preparing coatings based on the polymerization of tannic acid with iron(III) ions.40 The 
authors reported a general approach for the one-step formation of films in a wide 
variety of substrates, including inorganic, organic and biological templates. The capsules 
formed were observed to disassemble in acidic pH due to protonation of catechol 
moieties and therefore destabilization of cross-links. In addition, cytotoxicity was not 
observed in any iron-tannic acid coating tested. In a follow-up study, the authors also 
described a multistep assembly of iron(III)-tannic acid which exhibited different 
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properties than the ones made by one-step deposition, e.g. permeability, stiffness or 
degradability.41 Their pH-responsiveness was further exploited in the formation of  
doxorubicin-loaded metal-phenolic microcapsules using mesoporous CaCO3 particles as 
sacrificial templates.42 Capsules were prepared by the polymerization of tannic acid with 
Al(III), although Mn(II) and Gd(III) were also used for potential theranostic applications. 
As expected, their disassembly was observed to be pH-dependent, being relatively 
stable at pH 7.4 but degraded in a significant amount (80%) during 48 h at pH 5.0. In 
vitro assays also showed efficient capsule internalization and intracellular drug release, 
as well as comparable or even improved, in some cases, therapeutic effects. Moreover, 
encapsulation of other drugs such as irinotecan, topotecan or verapamil, was also 
proven in an analogous way.Ref? The same strategy was followed by Ju et al. using a 
mixture of catechol-functionalized hyaluronic acid and polyethyleneglycol instead of 
tannic acid.43 The resulting doxorubicin-loaded material showed an acid-triggered drug 
release along with enhanced targeting for CD44+ cancer cell line instead of CD44- cells 
due to the presence of hyaluronic acid and polyethyleneglycol. A further study showed 
the benefits of protein corona in such systems, improving target specificity.44 In a 
subsequent study, Park et al. used the previous approach to coat individual yeast cells.45 
Coated cells were found to retain their metabolic activities and viability, as well as an 
enhanced protection against binding of E. Coli, UV-C irradiation, lyticase and silver 
nanoparticles. Due to the pH-sensitive nature of their coating, cells could also be both 
preserved and exposed on-demand. Catechol-iron coordination was also used by 
Besford et al. to coat oleic acid nanoemulsions with a crosslinking of catechol-containing 
polyethyleneglycol and Fe(III) ions.46 The resulting doxorubicin-loaded nanostructures 
displayed an acid-induced drug release behavior. In vivo assays showed a stealth-like 
response with regards to cell association and a blood circulation half-life of 50 min. In 
vitro tests revealed significant cytotoxicity against human breast cancer cells, 
demonstrating successful cell internalization and intracellular release of the drug. 
Huang et al. recently reported the synthesis of Zn-based hexahistidine-metal 
nanoassemblies (HmA) for drug encapsulation.47 Such assemblies exhibited interesting 
properties such as an average size of 60 nm, the possibility of encapsulating from small 
molecules (fluorescein) to polymers (dextran-40k) and a loading capacity of up to 53%. 
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Moreover, a pH dependence was reported, with a burst release at pH 4.5 in minutes and 
a slow release at neutral pH. Minimal cytotoxicity and fast internalization were also 
reported for the HmA. In addition, encapsulation of the chemotherapeutic drug 
camptothecin improved the antitumor activity compared to the free drug.  
Not only coordination bonds within NCPs can trigger a pH-dependent response, but also 
the NCPs ligand design. As a proof-of-concept, Nador et al. compared the pH-
responsiveness of two structurally analogous bis(catechol)-based cobalt NCPs, 
containing either an imine functionality or an alkyl chain.18 Notably, NCPs composed by 
the imine-containing linker showed a loss of their spherical shape and aggregation at pH 
5.0, in addition to the disappearance of the characteristic imine infrared bands. 
However, NCPs treated at neutral pH preserved their morphology and chemical 
composition. Likewise, NCPs composed by the alkyl chain based linker confirmed the 
role of the imine moiety in the nanostructure disassembly, as they displayed great 
stability independent of the pH value used. Further examples include the nanostructures 
designed by Liu et al. based on Hf(IV) and an imine-based acid sensitive linker that were 
used for the encapsulation of the chemotherapeutic drug 
chloro(triphenylphosphine)gold(I) (TPPGC).48 These particles exhibited excellent 
stability at physiological pH but rapidly collapsed in mild acidic environments to release 
their cargo. In vitro and in vivo studies examined the feasibility of this system as 
combinational chemo-radiotherapy, due to the mixture of the encapsulated 
chemotherapeutic drug and hafnium ions that act as radio-sensitizers, showing an 
improvement as compared with conventional chemotherapy or radiotherapy. In 
addition, these nanostructures displayed no significant toxicity and their 
biodegradability could potentially avoid long-term toxicity concerns. In another study, 
Liu et al. further exploited this idea by encapsulating collagenase using a self-assembly 
between the previous imine-based acid sensitive linker and Mn(II) ions.49 After its 
PEGylation, these NCPs showed a similar pH-dependence than those of the previous 
work, being stable at neutral pH to degrade under acidic environments. In vivo studies 
demonstrated efficient accumulation within tumors. In addition, the released 
collagenase would allow an enhanced retention and permeation of a second wave of 
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therapeutic nanoparticles (chlorin e6 (Ce6)–loaded liposomes) which lead to an 
improved photodynamic therapeutic effect.  
Yang et al. described a series of nano-constructs formed by a dicarboxylic cisplatin (IV) 
prodrug, poly-L-histidine-PEG and a metal cation (Ca(II), Co(II), Ni(II), Hf(IV), Tb(III)).50 In 
this case, the NCPs experimented a charge conversion from slightly negative to positive 
upon a pH decrease from physiological to pH 5.5. Thus, these nanoparticles were stable 
under pH 7.4 but experimented a rather fast drug release at acidic pH. Such behavior 
was rationalized by the weakening of the histidine-metal bond by protonation of 
imidazole groups and further network collapse. Therapeutic efficacy of these NCPs were 
tested in vitro and in vivo, showing tumor suppression efficacy under relatively low drug 
doses. 
Wang et al. reported a concept of pH-responsive NCPs based on the coordination of 
Cu(II) and an organic linker containing the macrocycle dioxocyclam.51 In this approach, 
particles were formed by solvent-assisted precipitation of the corresponding soluble 
Cu(II)-linker. Upon a pH decrease, the dioxocyclam-Cu(II) complex was dissociated as the 
macrocycle was protonated, leading to the disassembly of the nanostructure. 
Interestingly, this work also demonstrated polymer collapse upon the addition of a 
competitive copper chelator (EDTA) at neutral pH. 
 
2.3. Other stimuli 
Concerning the use of other stimuli in NCPs, several examples have been recently 
reported. For instance, Zhang et al. developed a simple method for the fabrication of 
photodegradable nanostructures based on the self-assembly of Zn(II) and a 
bis(imidazole) ligand containing a photocleavable o-nitrobenzyl unit.52 These structures 
exhibited the capability to physically encapsulate different cargoes. Specifically, 
fluorescein, the antibiotic agent tetracycline or the chemotherapeutic drug doxorubicin, 
were separately encapsulated within the polymer network. Interestingly, their release 
in aqueous solution was significantly increased upon UV light irradiation when 
compared with no irradiated samples. In addition, in vitro experiments using HeLa cells 
showed no significant cytotoxicity for the non-loaded NCPs, while doxorubicin-loaded 
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NCPs retained a cytotoxic effect which became more evident upon irradiation, 
suggesting an enhanced drug release into the cells under these conditions. Liu et al. 
reported a strategy for light-controlled drug release based on Hf(IV) following an 
analogous approach to that used in the fabrication of a pH-sensitive NCPs for 
combinational chemo-radiotherapy.53 In this case, nanostructures were formed by the 
polymerization of a bis-(alkylthio) alkene linker (BATA), a singlet-oxygen sensitive ligand, 
and Hf(IV) cations. After loading with both photosensitizer chlorin e6 and 
chemotherapeutic drug doxorubicin, these NCPs were able to produce singlet oxygen 
upon red light irradiation, thus inducing drug release due to BATA cleavage and collapse 
of the nanoparticle. Notably, CT imaging and biodistribution measurements showed 
efficient tumor accumulation, while presenting an improvement for combined chemo-
photodynamic therapy and reduced toxicity when compared with the free drugs (Figure 
2). Hu et al. synthesized novel NCPs based on photochromic ligands for the potential 
encapsulation/release of cargoes upon light irradiation.54 In this study, microparticles 
formed by Zn(II) and a carboxylic-functionalized diarylethene photoswitch exhibited 
reversible photochromic behavior in the solid state and in solution. Remarkably, their 
change in surface area, pore shape and size upon interconversion by UV or visible light 
could provide a novel approach for light-triggered cargo release. 
 
Insert Figure 2 here 
Figure 2. (a) Schematic illustration for the synthesis of NCP-Ce6-DOX-PEG nanoparticles (b) TEM images 
of NCP-Ce6-DOX-PEG before and after light irradiation. (c) Sustained release of Ce6 and DOX from NCP-
Ce6-DOX-PEG with or without 660 nm LED light exposure at the power density of 5 mW cm-2. (d) Tumor 
growth curves of mice in different groups after receiving various treatments. Reproduced from reference 
53 with permission of the copyright holder. 
 
Cherepanov et al. reported the redox-dependent disassembly of gallic acid-Fe(III) 
networks.55 The authors evaluated the electrochemical reversibility of the system, 
identified the oxidation state of the redox-active species and showed that release of 
Fe(III) could be achieved, additionally identifying the specific conditions for “on-off” or 
continuous disassembly of the networks. Concerning redox-induced disassembly of 
nanostructures, Buywalda et al. developed micelles based on poly(ethylene glycol)-
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poly(N(2-hydroxypropyl)methacrylamide (PEG-P(HPMA)) including hydrophobic 4-
(methylthio)benzoyl side groups that could be crosslinked using the metal-organic linker 
[ethylenediamineplatinum(II)]2+.56 As a proof-of-concept, curcumin was encapsulated in 
such micelles with and without crosslinking. When compared to the free micelles, the 
crosslinking resulted in a smaller size, a lower critical micellar concentration and a better 
retention of the encapsulated drug. Drug release was found to be lower in the 
crosslinked micelles, however it was increased in the presence of dithioerythritol, which 
mimicked the presence of glutathione in the intracellular environment. 
 
2.4. Multi stimuli-responsive systems 
Li el al. reported a simultaneously pH- and glutathione-responsive nanoparticles 
composed by the self-assembly of Zn(II) and a histidine containing dipeptide or a 
amphiphilic histidine derivative (Figure 3).57 Moreover, the model drug chlorin e6 could 
be incorporated in loading capacities higher than 50% through cooperative coordination 
with the peptide and Zn(II). Importantly, the nanostructures displayed robust stability in 
physiological conditions but experimented a burst release upon either a pH decrease or 
a glutathione concentration increase. Owing to these features, these NCPs presented 
prolonged blood circulation lifetime, enhanced accumulation in tumors, improved 
antitumor efficacy compared to non-encapsulated photosensitizers and negligible in 
vitro or in vivo toxicities.  
Insert Figure 3 here 
 
Figure 3. (a) Construction of metallo-nanodrugs through cooperative coordination of small peptides and 
photosensitizers (Ce6) in the presence of zinc ions. (b) SEM images of the metallo-nanodrugs. (c) 
Schematic illustration and pictures showing the ultrasensitive response of Fmoc-H/Zn2+ to pH and GSH 
changes. (d) Ce6 release profiles from Fmoc-H/Zn2+/Ce6 in different release buffers. Unencapsulated Ce6 
was used as a control group. The lines are the fitted results according to the Gompertz kinetic release 
model. Error bars denote the standard deviation (n = 3). *P < 0.05 (one-way ANOVA). (e) Fluorescence 
images showing that Fmoc-H/ Zn2+/Ce6 and Z-HF/Zn2+/Ce6 allow better accumulation of Ce6 in tumor 
sites than unencapsulated Ce6. Reproduced from reference 57 with permission of the copyright holder. 
 
Another example of multistage responsiveness was reported by Liu et al.58 In this work, 
MnO2 nanoparticles stabilized by bovine serum albumin were prepared and coated with 
14 
 
a shell composed by the polymerization of Hf(IV) and c,c,t-
(diamminedichlorodisuccinato)Pt(IV) (DSP), a cisplatin prodrug. After a PEGylation step, 
the formed nanocomposite could act as a radio-sensitizer due to the presence of 
hafnium ions, as chemotherapeutic agent resulting from cisplatin release under 
reductive environments upon cell uptake or as magnetic resonance imaging contrast 
owing to the decomposition of MnO2 in the acidic tumor environment. In addition, MnO2 
could trigger decomposition of tumor endogenous H2O2 improving hypoxia-associated 
radiotherapy resistance. As a result of these factors, an efficient in vivo chemo-
radiotherapy was observed while the inherent biodegradability of NCPs and MnO2 lead 
to efficient excretion the nanocomposites with no appreciable toxicity. 
Wang et al. described an interesting example of drug release triggered by cellular 
endogenous species.59 Specifically, the authors designed a folic acid-PEG-poly(4-
vinylpyridine)-Ir(III)-2-phenylquinoline complex that self-assembled in water to form 
core-shell spherical nanoparticles with an average radius of 25 nm. Within this 
nanostructure, the Ir(III)-containing moiety acted as the core, whereas PEG remained in 
the shell. Remarkably, in vitro experiments revealed the interaction of intracellular 
histidine with the nanoparticles in order to release the iridium complex [Ir(pq)2]+ (pq = 
2-phenylquinoline), which served both as drug and as precursor of a phosphorescent 
emitter, thus enabling not only intracellular drug release but also phosphorescent 
tracking of its cellular internalization. 
The possibility of fine-tune and rationalize NCPs composition also allows the formation 
of multi-responsive systems that act as molecular logic gates. Pu et al. illustrated such 
behavior in nanostructures composed by the self-assembly of Tb(III) or Eu(III) ions and 
the nucleotide guanosine 5ʹ-monophosphate (GMP).60,61 These nanoparticles, after the 
encapsulation of N-methyl mesoporphyrin IX (NMM), exhibited fluorescence emission 
that could be described as the output of different binary logic gates when two or three 
distinct stimuli (inputs) were applied. Therefore, this input-dependent encapsulation 
could be used for controlled release and, simultaneously, cellular imaging. Gao et al. also 
reported GMP-lanthanide assemblies that could respond to several external stimuli such 
as dipicolinic acid, ethylene diamine tetraacetic acid, pH and Cu(II) or Hg(II) ions.62 In a 
similar way, Bai et al. described the core-cross-linking of a disulfide-containing 
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doxorubicin prodrug with Cu(II) to form nanoparticles that acted as an AND logic gate, 
i.e., output is released only if both inputs are present.63 In this example, inputs 
corresponded to acidic and reductive conditions, commonly found in cancer cells. Thus, 
premature drug release was observed to be suppressed under neutral and non-
reductive environments, but enhanced when both conditions, low pH and reducing 
agents, were accomplished. 
 
3. Nanoscale Coordination Polymers for Chemical Sensing 
The scope of application of NCPs as platforms for chemical sensing has also grown 
exponentially in the last years. Lanthanide-based NCPs nanoparticles constitute the 
main class of these nanostructures used as sensors for different chemical species, 
resting its performance in enhancing or quenching the fluorescence of a sample, in the 
presence of a certain analyte. In turn, Terbium (III) is the most common lanthanide ion 
used.64-78 
Tb(III) nanosensors, based on an enhancement of the fluorescence, can operate 
following three different mechanisms: i) by suppression of the inhibition of Tb(III)-ligand 
network fluorescence;64,65 ii) by sensitization of Tb(III) fluorescence;66,67 and iii) through 
the releasing of a fluorescent dye.68-70 Among the examples working by suppression of 
the inhibition of Tb(III)-ligand network fluorescence, Chen and coworkers demonstrated 
the utility of NCPs composed of Tb(III), adenine (Ad) as main constitutive ligand, and 
dipicolinic acid (DPA) as an auxiliary ligand sensitizer of the fluorescence of the metal, 
as a fluorescence nanosensor for Hg(II) (Figure 4).64 The fluorescence of the NCP network 
is very low due to a photoinduced electron transfer (PET) from adenine to DPA which 
avoids the expected intramolecular energy transfer from this molecule to Tb(III) that 
otherwise sensitizes the fluorescence of this atom. In the presence of Hg(II) a significant 
enhancement of fluorescence takes place due to the disappearance of the PET process 
as a consequence of the coordination of this metal to adenine. As nanosensor for Hg(II), 




Inset Figure 4 here 
 
Figure 4. The use of Tb(III) Coordination Polymer Nanoparticles for mercury(II) sensing constitutes a 
paradigmatic example of using the enhancement of fluorescence in presence of an analyte for sensing 
purposes. In this case, a suppression of the inhibition of Tb(III)-ligand network fluorescence in the 
presence of Hg (II) takes place. The fluorescence of the NCP network is very low due to a photoinduced 
electron transfer (PET) from adenine to DPA which avoids the expected intramolecular energy transfer 
from this molecule to Tb(III) that otherwise sensitizes the fluorescence of this atom. In the presence of 
Hg(II) a significant enhancement of fluorescence takes place due to the disappearance of the PET process 
as a consequence of the coordination of this metal to adenine. Reproduced from reference 64 with 
permission of the copyright holder. 
 
A similar strategy based on the enhancement of fluorescence of NCPs composed of 
Tb(III) ions has been described by Shi and coworkers for the selective sensing of 
biothiols, hydrogen peroxide or glucose in solution.65 The nanoparticles are made with 
Tb(III), the nucleotide guanosine monophosphate (GMP) as bridging ligand and Hg(II) 
which interacts with GMP and quenches the fluorescence of the Tb-GMP network. The 
as-prepared Tb–GMP–Hg nanoprobe can be used for the ‘‘turn on’’ fluorescent 
determination of several biothiols (Cys: cysteine, Hcys: homocystine, GSH: glutathione), 
through their high affinity for Hg(II), in a range between 10 and 1000 µM. Moreover, the 
addition of H2O2 reverses the Cys-mediated luminescence increase in the Tb–GMP–Hg 
probe, originating a ‘‘turn off’’ luminescent assay for H2O2 in concentrations between 1 
and 200 µM. The Tb–GMP–Hg- Cys material is also suitable for the detection of glucose, 
through the generation of H2O2, if the enzyme glucose oxidase (GOx) is incorporated in 
the system. 
An additional example of enhancing the fluorescence of Tb(III)-based NCPs to constitute 
an efficient nanoprobe is the reported by Tan et al. for the detection of antibiotic 
Ciprofloxacin.66 In this case, the NCP network is formed with Tb(III) and adenine as 
bridging ligand. A fluorescent emission of Tb(III) occurs in the presence of ciprofloxacin, 
due to the formation of a complex between this molecule with Tb(III) atoms on the 
surface on the NCPs. The thus obtained nanosensor presents a range of applications 
with linear enhancement of fluorescence between 60 nM to 14 µM. In the example 
presented by Cao and coworkers, the enhancement of fluorescence of NCPs composed 
of Tb(III) ions and the bis hydrazine of 4-formyl-3-hidroxybenzoic acid (HDBB) as 
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fluorescent bridging ligand, allowed the development of a fluorescent probe for zinc.67 
The Tb-HDBB network emits fluorescence at 590 nm when excited at 365 nm. Upon the 
addition of Zn(II), some carboxylic acid groups on the surface of the Tb-HDBB 
nanoparticles bind to this cation, resulting in the formation of new Tb-HDBB-Zn 
nanoparticles that present an additional increase in fluorescence emission at 470 nm 
with a concomitant decrease at 590 nm, providing a probe for the ratiometric assay for 
Zn(II) in a remarkable wide range from 100 nM to 60 µM. 
The last strategy for enhancing the fluorescence of a sample in the presence of an 
analyte consists of the encapsulation of an adequate dye in the NCPs. Thus, in the work 
reported by Mao and coworkers, NCPs composed of Tb(III) ions, GMP as constitutive 
ligand and the encapsulated fluorescent dye 7-amino-4-methyl coumarin, are used as a 
fluorescent probe for alkaline phosphatase (ALP) activity.68 The coumarin dye itself 
emits weak fluorescence while encapsulated, but upon the presence of ALP, the 
phosphate group in the GMP ligand is cleaved, resulting in the destruction of the Tb-
GMP network and the release of encapsulated coumarin dye into solution, causing the 
decrease in the fluorescence intensity emitted from the Tb-GMP network itself and the 
increase in the fluorescence intensity emitted from coumarin, providing a probe for the 
ratiometric assay for ALP in a range from 0.025 U/mL to 0.2 U/mL. Similarly, in a work 
reported by Ye and coworkers, heterobinuclear NCPs composed of Ce(III) and Tb(III) ions 
and the nucleotide AMP as constitutive ligand, provided a fluorescent probe for Hg(II).69 
In this case, a fluorescent dye (coumarin) was encapsulated to form nanoparticles which 
emit characteristic luminescence of Tb(III) at 548 nm after excitation, whereas coumarin 
itself emits weak fluorescence at 445 nm. In the presence of Hg(II), a strong coordination 
between AMP and Hg(II) occurs, resulting in the destruction of the Ce-Tb-AMP 
nanoparticles and the release of encapsulated coumarin dye into solution. As a result of 
this process, a quenching of the fluorescence intensity emitted from the Ce-Tb-GMP 
network takes place while increasing the fluorescence intensity emitted from coumarin, 
providing a double signal based nanoprobe for the ratiometric assay for Hg(II) in a wide 
range from 0.08 to 1000 nM. Following a closely related strategy, Li and coworkers 
reported NCPs composed of Tb(III) ions, GMP as binding ligand and an encapsulated NIR 
fluorescent hemicyanine dye (CyOH) as a fluorescent probe for alkaline phosphatase 
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(ALP) endogenous activity in biological samples, along with satisfactory tissue imaging 
capability at the depths of 40-120 µm.70 In the presence of ALP, phosphate bonds in the 
Tb-GMP network are cleaved, resulting in the destruction of the nanoparticles and the 
release of encapsulated CyOH into solution, originating from an increase of fluorescence 
intensity emitted by this dye that provides a NIR fluorescent nanoprobe for ALP activity 
in cells, tissues and mice. 
On the other hand, the quenching of fluorescence of different atoms in NCPs has been 
also a recurrent strategy for the development on nanosensors of different chemical 
species. Thus, Liu and coworkers described the use of NCPs nanoparticles as a tool for 
selective DNA homopolymers sensing and adsorption.71 Thus, a series of diverse NCPs 
between a nucleobase (adenine) or different nucleotides and various metal ions (Au(III) 
and Tb(III) among others) was prepared and tested for sensing of complementary DNA 
homopolymers. In the case of using Au(III) and adenine, the corresponding fluorescent 
NCPs can be used as a sensor for complementary DNA homopolymers due to a linear 
quenching of the fluorescence of the nanoparticles in a range of DNA concentrations 
between 5 to 20 nM. A similar strategy based on the quenching of fluorescence of NCPs 
composed of Tb(III) ions has been described by Song and coworkers for the selective 
sensing of hydrogen peroxide in biological fluids.72 The NCP network is formed with 
Tb(III)  phenylalanine as structural ligand and carboxyphenylboronic acid (CPBA) as guest 
ligand and sensitizer of the Tb(III) fluorescence. In the presence of H2O2 the fluorescence 
of the NPs is quenched as a consequence of oxidative deboronation of CPBA molecules 
and the corresponding intramolecular charge transfer (ICT) process from the formed 4-
oxo anions to the emissive state of lanthanide ions. The fluorescence of the nanosensor 
decreases linearly with the increase of H2O2 concentration from 6 µM to 1 mM and can 
be used in urine samples. In another example, Wu and coworkers reported the 
implementation of NCPs of Tb(III) as a selective fluorescent method for the sensing of 
Cu(II) in rat brain. The NCPs is composed of terbium ion, adenosine monophosphate 
(AMP) as main constitutive ligand and 5-sulfosalicylic acid (SSA) as an auxiliary ligand 
sensitizer of the fluorescence of Tb(III).73 The addition of Cu(II) into a solution of 
SSA/AMP-Tb nanoparticles strongly quenches the fluorescence because the specific 
coordination interaction between SSA and Cu(II) makes the energy transfer from SSA to 
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Tb(III) inefficient. The decrease in ratio of the fluorescence intensity of SSA/AMP-Tb 
shows a linear relationship for Cu(II) within a concentration range between 1.5 to 24 
μM. Eventually, by combining with micro-dialysis techniques, the method resulted 
successfully in the detection of cerebral Cu(II) in rat brain. Similarly, Chen and coworkers 
described the quenching of fluorescence of NCPs composed of Tb(III) ions for the 
selective sensing of nitrite ion (NO2-).74 In this case, the NCP network is formed with 
Tb(III) 5-fluorouracil as structural ligand and 4,4-oxybis(benzoic acid) (OBBA) as guest 
ligand and sensitizer of the Tb(III) fluorescence. In the presence of NO2- the florescence 
of the NPs is quenched as a consequence of an energy transfer from Tb(III) to NO2-. The 
response of the nanoprobe decreases linearly with the increase of NO2- concentration 
from 0.3 µM to 470 µM. In a study described by Qiu and coworkers, bimetal NCPs of 
Tb(III) and Ce(III) acted as a selective fluorescent probe for sensing of H2O2.75 The NCP 
network is formed using Tb(III) and Ce(III) and adenosine triphosphate (ATP) as the 
bridging ligand. The suitable emission energy of Ce(III) matching to the adsorption 
energy of Tb(III) allows an efficient energy transfer from Ce(III) to Tb(III), resulting in the 
characteristic fluorescent emission of Tb(III). This fluorescence can be switched off by 
oxidation of Ce(III) to Ce(IV) in the presence of H2O2, as a consequence of interrupting 
the energy transfer from Ce(III) to Tb(III). On the basis of this quenching mechanism, 
these nanoparticles are used to detect H2O2 in a wide range from 5 nM to 50 μM. If 
glucose oxidase is present in the system, glucose can be determined using this 
nanosensor. Similarly, Xiao and coworkers reported the use of bimetal NCPs of Tb(III) 
and Ce(III) as a selective fluorescent probe for ALP activity.76 The NCP network is 
generated using Tb(III) and Ce(III) and nucleotide GMP as the bridging ligand. As 
previously disclosed, an efficient energy transfer from Ce(III) to Tb(III) causes the 
characteristic fluorescent emission of Tb(III). This luminescence can be quenched by 
destruction of the Tb-GMP bonds by a dephosphorylation process in the presence of 
ALP, interrupting the energy transfer from Ce(III) to Tb(III). Based on this quenching of 
fluorescence, these nanoparticles are used to detect ALP in serum samples in a 
remarkable range from 0.05 U/mL to 20 U/mL 
In a study reported by Ye and coworkers, a combined strategy of sensitizing, quenching 
and enhancement of the fluorescence of Tb(III) (on-off-on switch) in NCPs is applied for 
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the selective sensing of histidine and cysteine.77 Thus, the nanoparticles were formed 
by self-assembly of AMP with Tb(III), and 5-sulfosalicylic acid (SSA) as an auxiliary ligand 
sensitizer of the fluorescence of Tb(III). The fluorescence of the AMP-Tb-SSA network is 
quenched by Cu(II), but is significantly enhanced by His and Cys, leading to a specific 
fluorescence “turn-on” assay for these amino acids by using Cu/SSA/AMP-Tb as a 
sensing nanoplatform. The enhancement of fluorescence resulted proportional to 
concentrations of His and Cys in the range from 0.2 to 150 μM and 0.5 to 200 μM, 
respectively. A similar strategy based on sensitizing, quenching and enhancement of the 
fluorescence of Eu(III) and Tb(III) in binuclear NCPs nanoparticles was applied by Wu and 
coworkers for the selective sensing of the anthrax biomarker dipicolinic acid (DPA).78 
The nanoparticles are made with Tb(III) and Eu(III) and the nucleotide GMP as bridging 
ligand and sensitizer to promote the Tb(III) luminescence at 549 nm without affecting 
Eu(III). Interestingly, the fluorescent emission of Eu(III) also appears at 620 nm because 
an effective energy transfer from Tb(III) to Eu(III) takes place. Upon the addition of DPA, 
a robust coordination with Tb(III) occurs, blocking this energy transfer between metals, 
causing the emission intensity of Tb(III) to increase during which a gradual decrease in 
the corresponding emission of Eu(III) is observed. The relative emission intensity 
(I549/I620) showed a linear response toward DPA within a concentration range from 2 
to 16 μM, thus originating in a dual emission luminescent nanoprobe for DPA. 
Remarkably, this sensor allowed for the real-time monitoring of DPA release from 
noninfectious spores of simulant bacteria for B. anthracis, B. subtilis. 
Besides Tb(III), other lanthanide ions such as Eu(III) and Ce(III) have been used to 
generate nanoprobes based on NCPs. Among the Eu(III)-based examples, Qu and 
coworkers reported the use of NCPs composed of Eu(III) ions, GMP as constitutive ligand 
and 4 different encapsulated fluorescent dyes, for the construction of an artificial 
tongue (Figure 5).79 Different metal ions interact distinctively with GMP, affecting in turn 
the fluorescence of the dyes, providing a fluorescent probe for the simultaneous sensing 
of several ions. In particular Ag(I) and Cu(II) concentrations can be univocally determined 
in a range from 0.1 to 50 μM. 
Inset Figure 5 here 
21 
 
Figure 5. Example of Eu(III)-based NCPs for chemical sensing. NCPs composed of Eu(III) ions, GMP as 
constitutive ligand and 4 different encapsulated fluorescent dyes, constitute an artificial tongue. 
Reproduced from reference 79 with permission of the copyright holder. 
 
Shi and coworkers described how NCPs composed of Eu(III) ions and fluorochrome 
riboflavin-5’-phosphate (RiP) as constitutive bridging ligand can act as a nanosensor for 
anthrax biomarker DPA.80 RiP in solution has a strong fluorescence at 536 nm but in the 
NCPs network this fluorescent emission decreases. Upon addition of DPA, the NCPs are 
broken, as a consequence of the strong interaction Eu(III) and DPA, resulting in the 
release of RiP and a concomitant enhancement of fluorescence, thus generating a 
nanosensor of DPA with a range of application between 0.04 and 1 µM. 
Following another strategy, Chen and coworkers described how NCPs composed of 
Eu(III), and isophthalic acid (IPA) as main constitutive ligand and sensitizer of the 
fluorescence of Eu(III), constitute a switch-on fluorescence nanosensor for Hg(II).81 The 
fluorescence of the NCP network is quenched in the presence of imidazole-4,5-
dicarboxilic acid (Im) due to an inner filter effect (iFE) of this compound that absorbs 
part of the emission luminescence of Eu(III). Upon the addition of Hg(II), a significant 
enhancement of fluorescence takes place due to the disappearance of the iFE process 
as a consequence of the coordination of Hg(II) to Im. As nanosensor for Hg(II), it presents 
a remarkable range of application between 2 nM to 2 µM, including applications in 
biological fluids. Similarly, Xu and coworkers reported an example of Eu(III)-based NCPs 
nanoparticles acting as an efficient turn-on fluorescent nanoprobe for the detection of 
antibiotic ciprofloxacin.82 In this case, the NCP network is formed with Eu(III) and GMP 
as bridging ligand. A fluorescent emission of Tb(III) occurs in the presence of 
ciprofloxacin, due to the formation of a complex between this compound and Eu(III) 
atoms. The thus obtained nanosensor presents a range of applications with linear 
enhancement of fluorescence between 1 to 40 µM. As previously referred, the anthrax 
biomarker DPA,78 and alkaline phosphatase activity,76 have also been the target of 
sensing by NCPs based on Eu(III) along with Tb(III). There are also several reported 
examples of using Ce(III)-based NCPs for chemical sensing. Thus, Qiu and coworkers 
described the use of fluorescent NCPs nanoparticles constructed by Ce(III), ATP as 
bridging ligand and units of tris(hydroxymethyl)aminomethane hydrochloric salt (Tris), 
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for hydrogen peroxide detection.83 ATP sensitizes the fluorescence of Ce(III) but upon 
the addition of H2O2, part of Ce(III) atoms in the ATP-Ce-Tris network are oxidized to the 
Ce(IV) state, by which a quenching of the fluorescence occurs. The decrease of emission 
intensity showed a linear response towards H2O2 within a remarkable concentration 
range from 0.6 nM to 80 μM, thus originating a switch-off luminescent nanoprobe for 
H2O2. If coupled with the GOx enzyme, the sensor probed to be also effective for glucose 
sensing in a range between 0.1 µM to 100 μM.  
Similarly, Lu and coworkers reported another switch-off fluorescent nanoprobe based 
on NCPs made of Ce(III), ATP as bridging ligand and Tris, for alkaline phosphatase activity 
sensing.84 In this case, in the presence of the ALP enzyme the ATP phosphate bonds are 
hydrolyzed, leading to the dissociation of the NCPs network and eventually to a decrease 
of the fluorescence. The fluorescence quenching efficiency shows a linear relationship 
for ALP in a range from 0.1 to 10 mU mL-1 and can be used in human serum samples. 
Other nanoprobes made of NCPs based on Ce(III) have previously been reported in this 
section for the sensing of DNA,71 H2O2,75 and Hg(II),69 in relation with Tb(III)-based 
nanosensors.  
NCPs based on other ions different from lanthanide metals have also been described as 
sensors. Thus, NCPs with useful sensing properties based on Fe(III) originated in situ 
from the decomposition of Fe(II) present in the compound ferrocenedicarboxylic acid 
(FcDA) has been reported by Mao and coworkers. These authors described that the 
photodecomposition of FcDC in methanol produces electroactive NCPs particles.85 
Under exposition to natural light, partial decomposition of ferrocene dicarboxylate takes 
place, generating Fe(II) which is oxidized to give Fe(III) that in turn, coordinates with 
carboxylic acids present in the FcDA units, thus generating the NCPs network. The 
resulting nanoparticles showed interesting properties in the presence of O2, as redox 
mediator in the reduction of O2 to H2O by the enzyme laccase. Tang and coworkers 
reported the use of bimetal Pt-Fe(III) NCPs for the sensing of the prostate specific 
antigen (PSA) used for prostate cancer prognosis.86 In this case, previously formed Pt 
NPs are encapsulated in the process of formation of the NCPs network between 
molecules of ferrocene dicarboxylate and Fe(III) generated by partial 
photodecomposition of the FcDA. Next, these nanoparticles are conjugated to anti-
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PSAantibody (Ab2) and deposited on an electrode surface functionalized with anti-
PSAantibody (Ab1), generating a sandwich-type electrochemical immune sensor based 
on the capacity of the platinum particles for catalytic H2O2 reduction. Upon addition of 
H2O2 to the solution, a current resulted proportional to the logarithm of PSA 
concentration in a remarkable range from 0.001 to 60 ng/mL. Cu(II) has also been used 
as constitutive metal in several NCPs applied for sensing purposes. Thus, Zhou and 
coworkers described the use of NCPs nanorods made of Cu(II) and tyrosine or aspartic 
acid as bridging ligands as enzyme-free electrochemical biosensor for H2O2.87 The 
material deposited on an electrode surface showed fast amperometic response in the 
presence of H2O2 in the range between 0.04 and 6.3 mM. Gai and coworkers reported 
NCPs, constructed by Cu(II) and GMP as bridging ligand, for H2O2 detection.88 In solution, 
the particles were able to oxidize 3,3’,5,5’-tetramethylbenzidine (TMB) to a blue colored 
product in the presence of H2O2, generating a colorimetric H2O2 assay based on the 
absorbance at 652 nm, in the range between 20 to 160 μM. If coupled with the GOx 
enzyme, the sensor probed to be also effective for glucose sensing ranging from 25 µM 
to 100 μM. In the case of Zn(II), Mao and coworkers described the use of NCPs made of 
Zn(II), 1,4-bis(imidazole-1-ylmethyl)benzene (bix) as bridging ligand, and the 
encapsulated dye Rhodamine B (RhB), as a colorimetric and fluorescent dual mode 
sensor to measure the alcohol content in spirit samples.21 In this case, the RhB-Zn(bix) 
nanoparticles are stable in pure alcohol, but upon the progressive addition of water the 
Zn(bix) network is destroyed, resulting in the release of RhB which confers color and 
fluorescent properties to the solution, constituting a colorimetric and fluorescent dual 
mode sensing of the alcohol strength, in a range between 20 and 100% where the values 
of real samples fall. Following a similar strategy, Cao and coworkers demonstrated the 
utility of NCPs composed of Zn(II), biphenyl-4,4’-dicarboxilic acid (BDA) as main 
constitutive ligand, and encapsulated fluorophore rhodamine B and quencher 
methylene blue, as a turn-on fluorescent nanosensor for phosphate in human serum.89 
The nanoparticles are disassembled in the presence of phosphate owing to the strong 
coordination between zinc and phosphate, liberating RhB into solution and triggering 
the corresponding fluorescence response, thus generating a switch-on fluorescent 
probe for PO43- in a range between 0.5 and 50 µM in human serum samples. 
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Other metals have been used as constitutive part of NCPs, but only in single examples. 
Co(II) in combination with 3,5-diterbutylcatechol and bix as constitutive ligands, was 
reported by Zhou and coworkers to form NCPs used as a colorimetric and fluorescence 
dual sensor for hypochlorite ions.90 Similarly to other studies using different metals, the 
liberation of encapsulated RhB upon the degradation of the nanoparticles by the 
influence of an analyte, generates a switch-on probe of it. In this case, ClO- destroys the 
NCPs network, liberating RhB and enhancing both color and fluorescence of the solution 
in a linear range from 1 to 400 µM of ClO-. Ye and coworkers described the use of nickel-
based NCPs as sacrificial template for the synthesis of nickel oxide nanostructures used 
as part of an urease-based bio-electrode for urea sensing.91 The NCPs are made with 
Ni(II) and benzene-1,4-dicarboxylic acid as constitutive bridging ligand. The prepared 
bio-electrode showed a linear response over the physiological range of urea 
concentration from 1.33 to 3.33 mM. Shen and coworkers reported the construction of 
a biosensor for glucose, using a modified electrode with glucose oxidase immobilized in 
a layer of Au-Ag-Pt core-shell nanoparticles, previously coated with a NCPs network 
formed between the Ag of the nanoparticles, H2PtCl6 and the ligand 2,5-dimercapto-
1,3,4-thiadiazole.92 The obtained biosensor showed a remarkable range for glucose 
sensing from 0.5 µM to 3.33 mM. 
 
4. Perspectives 
In spite of being at relative early stages of development (this novel family of 
nanoparticles was described for the first time 15 years ago), the results so far obtained 
in areas such as Nanomedicine and Sensors are really exciting. These nanoparticles do 
not exhibit an open-framework structure, but they can encapsulate different drugs with 
very high yields through both chemical and physical entrapment. Accordingly, different 
release routes have been explored such that the drugs have IC50 values similar to those 
of the free drug, even higher, while minimizing side effects. Moreover, it has already 
been shown that the coordination framework does not exhibit any toxicity (whenever 
the proper choice of metal ions and ligands are made). The chemical flexibility of these 
nanoparticles also allow for the fabrication of smart nanoparticles that respond to 
different external stimuli. Upon exposure to a given physiological media, the active units 
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are released to the media showing suitable efficiencies. This is one of the challenges 
followed nowadays in the field of drug release as ON/OFF systems are expected to 
significantly decrease undesired toxicities. The use of NCPs as platforms for chemical 
sensing has also grown exponentially over the last years. Lanthanide-based NCPs 
nanoparticles constitute without any doubt the main family of NCPs used as sensors for 
different chemical species; mainly, the fluorescence of a sample is enhanced or 
quenched in the absence/presence of a certain analyte. Therefore, NCPs offer a 
significant versatility and variety to develop new materials with ever-improved 
properties thanks to the countless combinations provided by coordination chemistry. 
Even though successful, there are still a lot of issues to be addressed, among them: 
• To understand the mechanisms that control the release of the drugs. For this, it 
is required to gain more control over the kinetics of: i) diffusion, ii) degradation 
of the nanostructure (which does not necessarily involve chemical degradation) 
or iii) a combination of both. Diffusion-induced delivery is modulated mainly by 
host-guest interactions, whereas degradation-induced diffusion through 
nanoparticle-body fluid interactions.  
• Another challenge to be faced in the near future is the fabrication of stable and 
monodisperse colloidal solutions by controlling the nature of the metal ions and 
ligands (though this approach could be limited by the need to incorporate active 
drugs) or surface modification. This last approach is expected to be more 
successful thanks to its inherent chemical flexibility and the surface modification 
of the nanoparticles with other active units such as fluorophores, PEG or even 
antibodies. 
• Finally, further studies yielding insight into their bio-distribution and bio-
degradation mechanisms are required. Development of proper pharmacokinetic 
profiles will be another major step. If successful, NCPs perform both detection 
and efficacy of a given therapy, foundational perspectives for “theranostics” or 
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